Clinical trial
Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment…
NCT00389493 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00389493 |
|---|---|
| Title | Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder |
| Official title | Maximizing Treatment Outcome in OCD |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Obsessive-Compulsive Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | Risperidone, Exposure/ritual prevention therapy (EX/RP), Placebo |
| Enrollment | 100 |
| Start date | Oct 1, 2006 |
| Primary completion | Jun 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Oct 18, 2006 |
| Last update posted | Apr 25, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: